PCR Devices Market Outlook Poised to Reach at a CAGR of 9.1% by 2024

The Global PCR Devices Market accounted to USD 2.4 billion in 2016 growing at a CAGR of 9.1% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Global PCR Devices Market By Technology (Digital PCR, Real-time PCR), By Product Type (Instrument, Reagent, Consumables, Others), By Application (Oncology, Blood Testing, Pathogen Detection, Research, Forensic, Others), By End User (Hospital, Diagnostic Center, Pharmaceutical and Biotechnology Companies, Clinical Research Organizations, Academia, Laboratories), By Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa)- Industry Trends and Forecast to 2024

Request for Sample Report Visit @: http://databridgemarketresearch.com/request-a-sample/?dbmr=global-pcr-devices-market

PCR devices have its applications in DNA sequencing, cloning, library generations, mutagenesis, expression profiling among others. PCR devices are thermal cycler which is commonly used in laboratories for amplifying the segments of DNA through polymerase chain reaction.

Competitive Analysis: Global PCR Devices Market

The PCR devices market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of PCR devices market for global, Europe, North America, Asia Pacific and South America.

Major Market Competitors: Global PCR Devices Market

Some of the major players operating in PCR devices market are Abbott Laboratories, Becton, Dickinson & Co., F. Hoffman-La Roche Ltd., Qiagen N.V., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Danaher Corporation, Takara Bio, Inc., Biomérieux S.A., Fluidigm Corporation, Merck KGaA, Promega Corporation, Analytik Jena AG among others.

Speak to Analyst Visit @ http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-pcr-devices-market 

Market Segmentation: Global PCR Devices Market

By technology the market for PCR devices is segmented into digital PCR and Real-time PCR.

By product type the PCR devices market is segmented into instrument, reagents and consumables and others. On the basis of application the market is segmented into oncology, blood testing, pathogen detection, research, forensic, others.

On the basis of end-users the PCR devices market is segmented into hospital, diagnostic center, pharmaceutical and biotechnology companies, clinical research organizations, academia, laboratories.

On the basis of geography, PCR devices market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, andBrazil among others. In 2017, North America is expected to dominate the market.

Major Market Drivers and Restraints:

• Rising incidences of infectious diseases and genetic disorders


• Increased usage of biomarkers for diagnosis of diseases


• Increasing government funding, investments and grants


• Technological advancement to adopt the new technology in PCR devices


• High initial costs for digital PCR devices


• Lack of knowledge and skilled professionals